ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ABVC ABVC BioPharma Inc

1.51
0.47 (45.19%)
Apr 23 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 8,641,601
Bid Price 1.51
Ask Price 1.52
News -
Day High 1.37

Low
0.6739

52 Week Range

High
9.60

Day Low 1.00
Share Name Share Symbol Market Stock Type
ABVC BioPharma Inc ABVC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.47 45.19% 1.51 18:59:49
Open Price Low Price High Price Close Price Previous Close
1.03 1.00 1.37 1.35 1.04
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
20,535 8,641,601 US$ 1.25 US$ 10,834,498 - 0.6739 - 9.60
Last Trade Type Quantity Price Currency
18:59:58 50 US$ 1.52 USD

ABVC BioPharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
14.26M 10.56M - 152k -10.52M -1.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ABVC BioPharma News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ABVC Message Board. Create One! See More Posts on ABVC Message Board See More Message Board Posts

Historical ABVC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.061.370.941.03565,1810.4542.45%
1 Month1.4051.450.941.242,021,4710.1057.47%
3 Months1.361.540.941.25770,5790.1511.03%
6 Months0.913.350.821.532,483,2770.6065.93%
1 Year6.609.600.67391.991,460,089-5.09-77.12%
3 Years33.20116.8830.673918.34996,456-31.69-95.45%
5 Years33.20116.8830.673918.34996,456-31.69-95.45%

ABVC BioPharma Description

ABVC BioPharma licenses promising medical research conducted in the Asia-Pacific region and enlists top-ranked principal investigators in the United States to conduct Phase II clinical trials. We specialize in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes that represent enormous commercial potential.

Your Recent History

Delayed Upgrade Clock